Literature DB >> 30270487

Risk factors for loss to follow-up, transfer or death among people living with HIV on their first antiretroviral therapy regimen in Mali.

A Baldé1, L Lièvre1, A I Maiga2, F Diallo3, I A Maiga4, D Costagliola1, S Abgrall1,5.   

Abstract

OBJECTIVES: Risk factors for loss to follow-up (LTFU) were assessed for people living with HIV (PLHIV) at various reference out-patient clinics (expertise level II) and hospitals (expertise level III) in Mali.
METHODS: HIV-1-positive adults starting antiretroviral therapy (ART) in 2006-2013 were eligible for inclusion. Risk factors for LTFU, defined as no visit in the 6 months preceding the last database update, were assessed with the Cox model, taking into account the competing risks of transfer and death. Potential risk factors at the start of ART were demographic and socioeconomic variables, World Health Organization (WHO) stage, CD4 count, period of ART initiation, type of ART, region of care, expertise level and distance from home.
RESULTS: We included 9821 PLHIV, 33% of whom were male, starting ART at nine out-patient clinics and seven hospitals [five and two in the capital Bamako and four and five in the 'regions' (i.e. districts outside the capital), respectively] with a median (interquartile range) CD4 count of 153 (56-270) cells/μL. Five-year cumulative incidences of LTFU, transfer and death were 35.2, 9.7 and 6.7%, respectively. People followed at Bamako hospitals > 5 km from home, at regional hospitals or at regional out-patient clinics < 5 km from home were at higher risk of LTFU than people followed at Bamako out-patient clinics, whereas people followed at regional out-patient clinics 5-50 km away from home were at lower risk for LTFU. Deaths were less frequent at hospitals, whether in Bamako or in the regions, than at Bamako out-patient clinics, and more frequent at regional out-patient clinics.
CONCLUSIONS: Expertise level and distance to care were associated with LTFU. Stigmatization may play a role for PLHIV living close to the centres in the regions.
© 2018 British HIV Association.

Entities:  

Keywords:  zzm321990HIVzzm321990; Mali; access to care; loss to follow-up; risk factors

Mesh:

Substances:

Year:  2018        PMID: 30270487     DOI: 10.1111/hiv.12668

Source DB:  PubMed          Journal:  HIV Med        ISSN: 1464-2662            Impact factor:   3.180


  4 in total

1.  Predictors of antiretroviral therapy interruptions and factors influencing return to care at the Nkolndongo Health District, Cameroon.

Authors:  Marius Nsoh; Katayi E Tshimwanga; Busi A Ngum; Avelina Mgasa; Moses O Otieno; Bokwena Moali; Nathanael Sirili; Ndeso S Atanga; Gregory E Halle-Ekane
Journal:  Afr Health Sci       Date:  2021-05       Impact factor: 0.927

2.  Baseline and Process Factors of Anti-Retroviral Therapy That Predict Loss to Follow-up Among People Living with HIV/AIDS in China: A Retrospective Cohort Study.

Authors:  Jinzhao Xie; Jing Gu; Xiuyuan Chen; Cong Liu; Haidan Zhong; Peishan Du; Quanmin Li; Joseph T F Lau; Chun Hao; Linghua Li; Yuantao Hao; Weiping Cai
Journal:  AIDS Behav       Date:  2021-10-26

3.  Factors Associated with Retention of HIV Patients on Antiretroviral Therapy in Care: Evidence from Outpatient Clinics in Two Provinces of the Democratic Republic of the Congo (DRC).

Authors:  Gulzar H Shah; Gina D Etheredge; Lievain Maluentesa Nkuta; Kristie C Waterfield; Osaremhen Ikhile; John Ditekemena; Bossiky Ngoy Belly Bernard
Journal:  Trop Med Infect Dis       Date:  2022-09-05

4.  Nearly one in every six HIV-infected children lost from ART follow-up at Debre Markos Referral Hospital, Northwest Ethiopia: A 14-year retrospective follow-up study.

Authors:  Yitbarek Tenaw Hibstie; Getiye Dejenu Kibret; Asmare Talie; Belisty Temesgen; Mamaru Wubale Melkamu; Animut Alebel
Journal:  PLoS One       Date:  2020-09-15       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.